Juluca Tablet, Film Coated
Product Images NDC 49702-242

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Juluca (NDC 49702-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dolutegravir Sodium Chemical Structure (Juluca Spl Graphic 01)

FDA Label Image

Rilpivirine Hydrochloride Chemical Structure (Juluca Spl Graphic 02)

FDA Label Image

Juluca 30 Count Label (Juluca Spl Graphic 03)

Juluca 30 Count Label (Juluca Spl Graphic 03)
Juluca is a prescription drug that comes in tablet form. Each tablet contains 50mg of dolutegravir and 25mg of rilpiviring. It is important to note that this drug should not be taken with certain medicines and the pharmacy label should not cover the ALERT message. The tablets should be stored in a cool, dry place and kept out of moisture. The manufacturer of the drug is ClaxaSmidoe and its distributor is located in Vade K, AP.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.